Natera Sells Evercord Cord Blood Banking Business to CBR Published on Sep 13, 2019  CU Cancer Center Team Wins $3M NCI Grant to Study Genetics of Aggressive Prostate Cancer Published on Sep 13, 2019  In Brief This Week: Illumina, Diagnomics, Danaher, BioDiscovery, Abbott Published on Sep 13, 2019  People in the News: Joel Smith, Manuel Méndez, Patrick Terry Published on Sep 13, 2019

Featured in Depth

Natera Finds High Performance for Noninvasive Prenatal Test in All Age Groups Published on Sep 13, 2019

10x Genomics CEO Says Firm 'Ready for Growth' Following $357.5M IPO Published on Sep 13, 2019

BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth Published on Sep 13, 2019

SciLifeLab, Broad Institute Researchers Go High Definition With Spatial Transcriptomics Published on Sep 12, 2019

Live Webinar: Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development Adrian Bot, VP of Translational Medicine at Kite, a Gilead Company, will explain how biomarker evaluation for CAR T-cell therapy can elucidate the mechanism of action and impact drug development. Register Here

Recommended for You

premium  Denmark's Samplix Plans Commercial Expansion to Support Rollout of Xdrop System Published on Sep 03, 2019 premium  Roche-GE Partnership Integrating Molecular Data Into Navify Tumor Board Published on Sep 11, 2019

How Does Navican Ensure Quality in its NGS Results? Download this on-demand video presentation to hear how Navican Precision Cancer Care has implemented a next-generation sequencing quality management system. Sponsored by SeraCare. Download it from GenomeWeb’s Webinar library.